BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27853909)

  • 1. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
    Munhoz RP; Bertucci Filho D; Teive HA
    Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
    Calzetti S; Negrotti A
    J Neurol Sci; 2023 Jan; 444():120526. PubMed ID: 36584558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
    Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
    Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
    Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
    Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
    Negrotti A; Calzetti S; Sasso E
    Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
    de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
    Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced parkinsonism].
    Kuzuhara S
    Nihon Rinsho; 1997 Jan; 55(1):112-7. PubMed ID: 9014432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
    Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
    Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
    Oh YS; Kwon DY; Kim JS; Park MH; Berg D
    Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced parkinsonism.
    Mena MA; de Yébenes JG
    Expert Opin Drug Saf; 2006 Nov; 5(6):759-71. PubMed ID: 17044803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
    Negrotti A; Calzetti S
    Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug induced parkinsonism: a common cause of parkinsonism in older people.
    Thanvi B; Treadwell S
    Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism associated with calcium channel blockers: a prospective follow-up study.
    García-Ruiz PJ; García de Yébenes J; Jiménez-Jiménez FJ; Vázquez A; García Urra D; Morales B
    Clin Neuropharmacol; 1992 Feb; 15(1):19-26. PubMed ID: 1349506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced parkinsonism.
    Shin HW; Chung SJ
    J Clin Neurol; 2012 Mar; 8(1):15-21. PubMed ID: 22523509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced parkinsonism: a review.
    Montastruc JL; Llau ME; Rascol O; Senard JM
    Fundam Clin Pharmacol; 1994; 8(4):293-306. PubMed ID: 7851836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs].
    Martí Massó JF; Poza JJ
    Neurologia; 1996 Jan; 11(1):10-5. PubMed ID: 8714170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-induced parkinson syndromes].
    Nguyen N; Pradel V; Micallef J; Montastruc JL; Blin O
    Therapie; 2004; 59(1):105-12. PubMed ID: 15199676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
    Miguel R; Correia AS; Bugalho P
    J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of parkinsonism in a Brazilian movement disorders clinic.
    Cardoso F; Camargos ST; Silva Júnior GA
    Arq Neuropsiquiatr; 1998 Jun; 56(2):171-5. PubMed ID: 9698723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.